Myriad Genetics

MYGN

MYGN
Myriad Genetics Stock Quote
$27.80 -$0.72 -2.5%
BATS BZX Real Time Price as of September 18, 2019, 4:00 p.m. EDT View Interactive MYGN Charts

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

News & Analysis: Myriad Genetics

The Fool has written over 100 articles on Myriad Genetics.

All

Market Moves

Earnings


3 Cancer Treatment Stocks to Buy Right Now

Cancer is one of the toughest diseases to fight, and these companies are playing a great role in helping people combat it.


Myriad Genetics Limps Into Fiscal 2020

A sluggish end to fiscal 2019 and weaker-than-expected guidance for the year ahead aren't instilling much confidence in investors.









Interactive Chart